LTP Trademark

Trademark Overview

On Friday, December 7, 2018, a trademark application was filed for LTP with the United States Patent and Trademark Office. The USPTO has given the LTP trademark a serial number of 88221060. The federal status of this trademark filing is REGISTERED as of Tuesday, August 17, 2021. This trademark is owned by Ligand Pharmaceuticals, Inc.. The LTP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development of a process to deliver organ specific pharmaceutical preparations
ltp

General Information

Serial Number88221060
Word MarkLTP
Filing DateFriday, December 7, 2018
Status700 - REGISTERED
Status DateTuesday, August 17, 2021
Registration Number6456158
Registration DateTuesday, August 17, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements

Pseudo MarkLIGAND PHARMACEUTICALS
Goods and ServicesPharmaceutical research and development of a process to deliver organ specific pharmaceutical preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 30, 2018
Primary Code042
First Use Anywhere DateSaturday, April 14, 2018
First Use In Commerce DateWednesday, April 18, 2018

Trademark Owner History

Party NameLigand Pharmaceuticals Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJupiter, FL 33458
Party NameLigand Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameLigand Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Sunday, December 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 7, 2019ASSIGNED TO EXAMINER
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 13, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, December 11, 2018NEW APPLICATION ENTERED
Friday, March 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2019SOU EXTENSION 1 FILED
Monday, November 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 18, 2019SOU EXTENSION 1 GRANTED
Tuesday, June 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020SOU EXTENSION 2 FILED
Monday, June 15, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021USE AMENDMENT FILED
Tuesday, June 8, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 14, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 17, 2021REGISTERED-PRINCIPAL REGISTER
Sunday, October 31, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, October 31, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, October 31, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 7, 2020SOU EXTENSION 3 FILED
Monday, December 7, 2020SOU EXTENSION 3 GRANTED
Friday, June 4, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, July 15, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, October 31, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 26, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 26, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, October 31, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

pharmaceutical specific preparations organ process research development deliver